Search results

HRA presentations were well attended at this year’s NHS R&D Forum Annual Conference which took place on 23 - 24 May 2016 in Stratford-Upon-Avon.

The HRA Approval Programme today issues an update on performance. HRA Approval for new studies is being issued in line with plans. Requests for HRA Approval for existing studies and for amendments has been higher than expected, and actions for clearing the backlog are set out

The Nuffield Council on Bioethics has published a statement of aspiration on how health research can be improved by working collaboratively with young people, children and their parents which is welcomed by the Health Research Authority.

Following the result of the referendum on the UK’s membership of the European Union, the focus of the Health Research Authority to promote and protect the interests of patients and the public in health and social care research continues.

The HRA Approval Programme today issues another update on performance. HRA Approval for new studies continues to be issued in line with plans. Requests for HRA Approval for existing studies and for amendments have been higher than expected but have now reduced to near-expected levels. The update shows how we are working to process these and clear the backlog.

The Department of Health (DH) and the Health Research Authority (HRA) have been working together to review the standard DH contract for NIHR funded research. From today research funded by an NIHR research programme will be able to receive payments for start-up in advance of ethical approval. This enables more rapid, efficient and streamlined set-up of research and quicker translation of research into patient benefit.

The Medical Research Council (MRC) working with the Medicines and Healthcare Products Regulatory Agency (MHRA) and Health Research Authority (HRA) has submitted a joint response to the Innovative Medicines Initiative (IMI) consultation on Advanced Therapies Concept Paper.

The EU Commission’s Directorate General for Health and Food Safety (DG SANTE) Clinical Trials Regulation has recently consulted on four documents developed in preparation for the implementation for the Clinical Trials Regulation (EU) No 536/2014.

This consultation follows the independent review of data security, consent and opt-outs by National Data Guardian Dame Fiona Caldicott.

The European Medicines Agency (EMA), in cooperation with the European Commission and the Member States of the European Union (EU), has recently consulted on a concept paper on the revision of the ‘Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products’.

In response to requests, the Health Research Authority (HRA) has published a new brief leaflet setting out high level information about the HRA Approval process. It provides an overview, highlighting our aim to simplify and streamline the approval process.

Three research ethicists with close links to the Health Research Authority have been recognised in the Queen’s New Year’s Honours for a combined total of nearly 45 years’ service to Research Ethics Committees.

We’re about to begin work to improve the HRA website – we want to make it easier to access the information you need. We’d love to hear your thoughts on what you like and don’t like about our current site, and what new features would make your life easier.

The HRA is encouraging researchers to take a more proportionate approach to the process of seeking consent for participation in research.

Registration for this event has now closed due to a large number of expressions of interest. Those who obtained a place will be contacted on Monday 13th February 2017.

It is with great sadness that we hear of the news of the death of a close friend of the Health Research Authority, Dr Richard Tiner. A former general practitioner in the South West of England for many years, Richard was medical director of the Association of British Pharmaceutical Industry from 1996 – 2009.

What are the circumstances under which it is acceptable to use confidential patient and service user information without consent for purposes beyond direct patient care?

The range of independent advice and expertise available to the Health Research Authority has been broadened with the expansion in March of the HRA’s national panel of experts.

If you are a researcher who needs to explain the risks of ionising radiation to your study participants, then we have produced some generic statements to help you.

The Annual NHS R&D Forum is taking place in Manchester on 15 - 16 May 2017 – the must-attend meeting of the year for those working in health and care research management, support and leadership.